Say hello to MassDevice +3Blogs, a bite-sized view of the top three med-tech blogs of the week. This latest feature of MassDevice.com’s coverage highlights our three favorite blogs of the week to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +3Blogs.
Minor five-minute changes to administrative charting requirements aren’t so minor, especially when you add more time for quality assurance reporting or pay-for-performance initiatives. Suddenly huge swaths of time from a doctor’s opportunity to take care of their patients. We need more care time and less data entry time, wrote Westby Fisher.
In many cancers chromosomes get reshuffled, with sections breaking off and attaching to other chromosomes in what are called translocations. Fred Alt and his team are trying to better understand where chromosomes are most likely to break and where the broken pieces are most likely to attach, knowledge that could help better understand some aspects of cancer, reported Children’s Hospital Boston’s Tom Ulrich.
It is generally known that a prescription drug manufacturer must obtain state licenses in order to legally distribute product and that the number of licenses required varies depending upon the method of distribution. But what about devices? Device companies are beginning to realize is that they too have licensing requirements in numerous states, reported Frank Fazio.